Recombinant Human Rab17 Protein Summary
A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 1-212 of Human Rab17
Source: E.coli
Amino Acid Sequence: MGSSHHHHHH SSGLVPRGSH MAQAHRTPQP RAAPSQPRVF KLVLLGSGSV GKSSLALRYV KNDFKSILPT VGCAFFTKVV DVGATSLKLE IWDTAGQEKY HSVCHLYFRG ANAALLVYDI TRKDSFLKAQ QWLKDLEEEL HPGEVLVMLV GNKTDLSQER EVTFQEGKEF ADSQKLLFME TSAKLNHQVS EVFNTVAQEL LQRSDEEGQA LRGDAAVALN KGPARQAKCC AH
E. coli
Recombinant Protein
RAB17
>90%, by SDS-PAGE
Applications/Dilutions
25.6 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Packaging, Storage & Formulations
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
20mM Tris-HCl buffer (pH8.0) containing 30% glycerol, 0.1M NaCl, 1mM DTT
No Preservative
0.5 mg/ml
>90%, by SDS-PAGE
Alternate Names for Recombinant Human Rab17 Protein
- FLJ12538
- RAB17, member RAS oncogene family
- ras-related protein Rab-17
Background
RAB17, also known as Ras-related protein Rab17, belongs to the small GTPase superfamily, Rab GTPases are localized to various intracellular compartments and are known to play important regulatory roles in membrane trafficking. It is regulated traffic through the apical recycling endosome, suggested function in polarized sorting in epithelial cells. Recombinant human RAB17 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets : P9X Receptor inhibitors